Population Health Research Institute

What Population Health Research Institute does

Population Health Research Institute (PHRI) is a non-profit academic health research institute founded in 1999 and headquartered in Hamilton, Ontario, Canada, operating as a joint institute of McMaster University and Hamilton Health Sciences. PHRI conducts trans-disciplinary population health and clinical research across 14 therapeutic areas including cardiovascular disease, stroke, diabetes, brain health, cancer survivorship, infectious diseases, perioperative medicine, renal disease, and digital health, with research encompassing more than 1.3 million participants across 105 countries and 6 continents. The institute operates landmark longitudinal programs such as the PURE study (225,000 detailed participants across 27 high-, middle-, and low-income countries) and runs large-scale pharmaceutical-sponsored randomized controlled trials for sponsors including Bayer, AstraZeneca, Janssen, Boehringer Ingelheim, Novartis, Sanofi, Roche, Abbott, Medtronic, and AtriCure.

PHRI's core technical infrastructure comprises the CRLB-GMEL laboratory (multi-omics, biomarker analysis, biobanking, bioinformatics), the Research Data Operations (RDO) department that builds and maintains study databases, a Biostatistics department supporting design and analysis of multinational trials, the Program Management function, and the ROME Portal — an internal research operations management platform. These capabilities enable PHRI to coordinate over 1,500 research sites in 102 countries and serve as the coordinating hub for multiple national and international research networks including PHRI International, AF-SCREEN, C-SPIN, CoHESIVE, IMAGINE-SPOR, and the ACT/AEC Consortium.

PHRI's business model is that of an academic research organization: it does not sell commercial products or services, instead generating operating funds through peer-reviewed government grants (notably from CIHR and the Heart and Stroke Foundation of Canada), charitable foundations (Bill & Melinda Gates Foundation, Wellcome), pharmaceutical and medical device industry-sponsored clinical trial contracts, and institutional support from McMaster University and Hamilton Health Sciences. Its primary 'customer' base consists of global trial sponsors, government funding bodies, and the broader research community that consumes its publications in top-tier journals such as Lancet, NEJM, and JAMA. Founded by Salim Yusuf (now Emeritus Executive Director), PHRI is currently led by Interim Executive Director Hertzel Gerstein and a senior leadership team including Deputy Director PJ Devereaux, Associate Deputy Director Emilie Belley-Cote, and Head of Operations Jessica Vincent.

Name

Population Health Research Institute

Legal name

Population Health Research Institute

Website

https://phri.ca

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

251–500 employees

Short description

Population Health Research Institute is a non-profit academic health research institute, jointly affiliated with McMaster University and Hamilton Health Sciences, that conducts large-scale multinational clinical trials and epidemiological studies across 14 therapeutic areas for global pharmaceutical sponsors and government funders.

Ownership category

akta.pro rank

Product category

Clinical Research Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industries

Real-World Evidence (RWE), HEOR & Epidemiology CROs (HLAGAAAK), Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE)

Keywords

• Clinical research services
• Epidemiological studies
• Clinical trial management
• Population health research
• Cardiovascular research

Headquarters

HQ city

Hamilton

HQ country

Canada

HQ region

North America

Offices3 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Marketing channels4 records

Core offering

Population Health Research Institute conducts large-scale multinational clinical trials, registries, and epidemiological studies covering cardiovascular disease, stroke, diabetes, perioperative care, infectious diseases, and global population health. Its offerings include the PURE prospective epidemiological study platform (225,000+ participants across 27 countries), the CRLB-GMEL laboratory for genetic and biomarker analysis, biostatistics and study design services, program management for multi-site trials, and Research Data Operations for clinical study databases. PHRI is a joint institute of McMaster University and Hamilton Health Sciences and operates as a nonprofit academic research organization.

Product overview

PHRI is a joint institute of McMaster University and Hamilton Health Sciences that conducts trans-disciplinary health research rather than commercial product offerings. Its core research infrastructure includes the PURE epidemiological study platform (involving over 225,000 participants across 27 countries), the CRLB-GMEL laboratory service (offering multi-omics, biomarker analysis, and biobanking), and the ROME Portal for research data operations. Supporting services include biostatistics, program management, and research data operations. PHRI's research activities encompass clinical trials across multiple therapeutic areas including cardiology, stroke, digital health, and global population health.

Differentiator

Problem solved

Functional benefit

Products and services

• PURE (Prospective Urban and Rural Epidemiological study) Large-scale ongoing observational epidemiological study involving over 225,000 participants with detailed information and 500,000 with simple information across more than 1,000 urban and rural communities in 27 high, middle, and low-income countries; investigates cardiovascular disease, diabetes, lung diseases, cancers, kidney disease, brain health, and injuries for academic and policy audiences.
• CRLB-GMEL Laboratory Laboratory providing genetic analysis using multi-omics, biomarker analysis, biobanking, and bioinformatics services to support PHRI research studies and collaborating investigators.
• Research Data Operations (RDO) Department that supports PHRI studies by planning, building, and maintaining high-quality study databases and related data systems, ensuring data are handled consistently, accurately, and in line with PHRI's standards and processes.
• Biostatistics Services PHRI's Statistics department contributes to design, statistical analysis, and data management reporting of studies, with analysts working on large-scale multinational clinical trials, registries, and epidemiological projects to ensure a robust, reliable data platform.
• Program Management Program directors, managers, and research coordinators who support study conduct from initial design to completion and publication, including activity at investigative sites, sponsors internationally, and across PHRI's global network.

Quantifiable outcome

• PURE study demonstrated that large differences in death rates between poor and rich countries were due to differences in healthcare rather than risk factors
• +2 more outcomes

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

16 partnerships are on record, tiered core and major.

• PHRI InternationalcoreStrategic or Co-development Partner · 1 November 2019PHRI's long-standing collaborations with a global network formalized as PHRI International - a large global family of researchers formally united, resulting in many research successes.
• McMaster UniversitycoreStrategic or Co-development PartnerPHRI is a joint institute of McMaster University and Hamilton Health Sciences. The partnership provides academic affiliation, research collaboration, faculty connections, and student/trainee pipeline.
• Hamilton Health SciencescoreStrategic or Co-development PartnerPHRI is a joint institute of Hamilton Health Sciences and McMaster University. This partnership provides clinical research settings, hospital connections, and healthcare system integration.
• AF-SCREEN International CollaborationmajorStrategic or Co-development PartnerMore than 150 experts in atrial fibrillation from 37 countries collaborate to promote discussion and research about screening for unknown or under-treated AF to reduce stroke and death. PHRI's Jeff Healey, David Conen, Stuart Connolly, and William McIntyre are members.
• Canadian Stroke Prevention Intervention Network (C-SPIN)majorStrategic or Co-development PartnerFounded in October 2013 and led by PHRI Senior Scientist Jeff Healey. Links researchers from across Canada in medicine, surgery, nursing, pharmacy, population health, and social sciences with support from CIHR, Heart and Stroke Foundation, and industry partners.
• CoHESIVE (Canadian Hemorrhagic Stroke Trials Initiative)majorStrategic or Co-development PartnerA Canada-wide multidisciplinary network created in 2017 to improve understanding of bleeding in the brain, develop prediction tools and prevention strategies. Executive team includes PHRI's Ashkan Shoamanesh, Robert Hart, Stuart Connolly, John Eikelboom, Jeff Healey, Gui Paré and Mike Sharma.
• IMAGINE-SPOR Chronic Disease NetworkmajorStrategic or Co-development PartnerNetwork on Inflammation, Microbiome, and Alimentation focusing on patients with IBS, IBD and healthy controls. Led by Paul Moayyedi, PHRI senior scientist and McMaster gastroenterologist. Program management provided by Tara McCready, PHRI.
• Thrombosis & Atherosclerosis Research Institute (TaARI)majorStrategic or Co-development PartnerShares space with PHRI in the David Braley Research Institute building. PHRI's Gui Pare, Sonia Anand, John Eikelboom, and Hertzel Gerstein collaborate with TaARI on experimental thrombosis, atherosclerosis, and clinical thromboembolism programs.
• Accelerating Clinical Trials (ACT/AEC) ConsortiumcoreStrategic or Co-development PartnerA pan-Canadian clinical trials consortium bringing together hundreds of researchers from 28 networks, 11 trial units, patient-partners, biotechnology industry, government, and experts in research ethics review, contracts, insurance, regulatory processes, patient engagement, and clinical trials training.
• Canadian Heart Function (CHF) AlliancemajorStrategic or Co-development PartnerPHRI is a foundational partner in the Canadian Heart Function Alliance network bringing together 132 Canadian researchers and clinical experts in heart failure, patients, and more.
• Firestone Institute for Respiratory HealthmajorStrategic or Co-development PartnerFIRH conducts research in respiratory health and disease. PHRI collaborates with investigators in respiratory research, such as MyLinh Duong, to lead the world's largest study in lung health.
• Chanchlani Research CentremajorStrategic or Co-development PartnerEstablished in 2011 at McMaster University, works in areas of omics (genomics, proteonomics etc.) led by Sonia Anand. Featured projects include genetics of opioid addiction and Canadian Alliance of Healthy Hearts and Minds (CAHHM).
• Escarpment Cancer Research Institute (ESCRI)majorStrategic or Co-development PartnerA joint McMaster University/Hamilton Health Sciences institute conducting clinical trials and quality health care research. PHRI scientists collaborate to develop studies in cardio-oncology and cancer epidemiology.
• London School of Hygiene and Tropical MedicinemajorStrategic or Co-development PartnerAcademic partner collaborating on PURE study with researchers McKee, B Palafox, A Murphy, D Balabanova.
• Harvard UniversitymajorStrategic or Co-development PartnerAcademic partner collaborating on PURE study with S V Subramanian.
• The George Institute for Global HealthmajorStrategic or Co-development PartnerInternational research institute collaborating on PURE study with C Chow.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• ICON plc: Global commercial CRO with strong cardiovascular and outcomes research practice following the PRA Health Sciences merger. Broad incumbent peer to PHRI in clinical trial execution, with much larger commercial scale.
• IQVIA: Largest global commercial CRO with deep cardiovascular and real-world evidence capabilities. Broad incumbent peer given overlap in trial execution and data infrastructure, though IQVIA is a commercial entity serving pharma at far greater scale.
• Mayo Clinic: Large US academic medical center with extensive clinical and translational research infrastructure. Comparable to PHRI as a peer academic research institution with hospital integration, though Mayo operates at significantly larger scale and across many more therapeutic areas.
• CHARLES RIVER LABORATORIES: Global contract research organization spanning discovery, safety, and clinical trial services. Broad incumbent peer given overlap in clinical research services and lab capabilities, though CRL is a commercial entity focused on early-stage and preclinical work as well.

Direct peers

• The George Institute for Global Health: Independent global medical research institute focused on large-scale population health and clinical trials across cardiovascular, diabetes, and critical care. Direct peer to PHRI given shared global footprint, large multinational trial portfolio, and academic affiliation model.
• London School of Hygiene & Tropical Medicine (LSHTM): Academic global health research institution with large-scale epidemiological cohort studies and clinical trials across LMICs. PHRI explicitly collaborates with LSHTM on the PURE study, making it a tightly comparable peer in population health methodology.
• Duke Clinical Research Institute (DCRI): Academic clinical research organization at Duke University running large multinational cardiovascular and outcomes trials with pharma funding. Comparable to PHRI in trial scale, biostatistics capability, and industry-funded clinical research model.
• Clinical Trial Service Unit (CTSU), University of Oxford: University of Oxford's large-scale randomized trials and epidemiology unit. Highly comparable peer — Yusuf himself trained at Oxford and co-developed the 'large, simple trial' methodology at CTSU, and CTSU's portfolio structure mirrors PHRI's.
• TIMI Study Group (Brigham and Women's Hospital): Academic cardiovascular clinical trials group that designs and executes large multinational outcome trials with pharma sponsors. Direct peer in cardiovascular trial leadership, statistical rigor, and guideline-influencing study portfolio.
• Canadian VIGOUR Centre (University of Alberta): Canadian academic cardiovascular clinical trials group running multinational outcome studies. Comparable to PHRI in scope (cardiovascular focus), academic affiliation, and industry-funded large trial execution.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Instagraminstagram.com/phri
• Xx.com/phriresearch
• LinkedInlinkedin.com/company/phriresearch

Revenue estimate

Valuation estimate

Number of profiles

Profiles19 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Population Health Research Institute